Bone Health (Issue 1) | Special Reports

In Practice: Bone Health in Women With Breast Cancer

December 17, 2014

Clinical Articles

Women undergoing therapy for breast cancer are at increased risk for loss of bone mineral density (BMD) and fractures because of the use of adjuvant estrogen-lowering therapies (ie, aromatase inhibitors).

Teaching Patients About Bone Health in Breast Cancer

December 17, 2014

Clinical Articles

Most women are aware that bone density frequently decreases with age and natural menopause, but many women do not know that breast cancer treatments can reduce bone density and increase the risk of fracture.

Compliance in Metastatic Bone Disease Treatment Explored

December 17, 2014

Clinical Articles

Bone-targeted agents may help to minimize complications associated with osseous metastases, such as skeletal-related events, but ongoing compliance and adherence to these therapies are important to ensure they provide the desired benefit.